NYSE: HCAHCA Healthcare Inc Stock
$209.33+1.49 (0.72%)
Updated May 6, 2021
HCA Price
$209.33
Fair Value Price
N/A
Market Cap
$71.15B
52 Week Low
$91.21
52 Week High
$209.84
P/E
15.4x
P/B
288.08x
P/S
1.21x
PEG
2.62x
Dividend Yield
0.39%
Revenue
$52.65B
Earnings
$4.60B
Gross Margin
38.2%
Operating Margin
14.17%
Profit Margin
8.7%
Debt to Equity
181.36
Operating Cash Flow
$10B
Beta
1.07
Next Earnings
N/A
Ex-Dividend
Jun 15, 2021
Next Dividend
Jun 30, 2021
Zen Score
High
Medium
Low
38
Industry average
Reasons for this score
HCA ($209.33) is trading below its intrinsic value of $520.04, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
HCA is good value based on its earnings relative to its share price (15.4x), compared to the US market average 27.98x)
Valuation
HCA is good value based on its earnings relative to its share price (15.4x), compared to the US Medical Care Facilities industry average (-3.92x)
Valuation
HCA News
Valuation
HCA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
15.4x
Industry
-3.92x
Market
27.98x
HCA is good value based on its earnings relative to its share price (15.4x), compared to the US market average 27.98x)
Valuation
HCA is good value based on its earnings relative to its share price (15.4x), compared to the US Medical Care Facilities industry average (-3.92x)
Valuation
HCA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
288.08x
Industry
6.98x
Market
0.6x
HCA is poor value based on its book value relative to its share price (288.08x), compared to the US market average (0.6x)
Valuation
HCA is poor value based on its book value relative to its share price (288.08x), compared to the US Medical Care Facilities industry average (6.98x)
Valuation
HCA price to earnings growth (PEG)
For valuing profitable companies with growth potential
HCA is poor value relative to its rate of earnings growth, measured by PEG ratio (2.62x)
Valuation
HCA's financial health
Profit margin
Revenue
$14.0B
Net Income
$1.4B
Profit Margin
10.2%
HCA's Earnings (EBIT) of $7.46B are insufficient to safely cover interest payments on company debt ($32.80B)
Financials
HCA's profit margin has increased (+2.8%) in the last year from (5.9%) to (8.7%)
Financials
Assets to liabilities
Assets
$47.3B
Liabilities
$44.8B
Debt to equity
132.8
HCA's short-term assets ($12.04B) exceed its short-term liabilities ($8.64B)
Financials
HCA's long-term liabilities ($36.15B) exceed its short-term assets ($12.04B)
Financials
HCA's debt relative to shareholder equity (181.36) has decreased or remained constant compared to 5 years ago (-5.13)
Financials
HCA's debt to equity ratio (181.36) is considered high
Financials
Cash flow
Operating
$2.0B
Investing
-$649.0M
Financing
-$2.1B
HCA's operating cash flow ($9.85B) is sufficient to service the company's debt ($32.80B)
Financials
HCA Healthcare Stock FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.